MedPage Today November 15, 2024
Greg Laub

— Long-lived plasma cell compartment in the bone marrow may hold the answer, says researcher

The inability of COVID vaccines to reach the long-lived plasma cell compartment in the bone marrow may explain their waning protection compared with vaccines for influenza or tetanus, according to a recent study published in Nature Medicine.

In this exclusive MedPage Today video, study author Frances Eun-Hyung Lee, MD, of Emory University School of Medicine in Atlanta, discusses the findings and the implications for future research.

Following is a transcript of her remarks:

The COVID mRNA vaccines were introduced in 2021, and it’s really made a game changer for us to get out of the pandemic. But the one question is how long did those...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Govt Agencies, Healthcare System, Patient / Consumer, Provider, Public Health / COVID
Scientists Fear What's Next for Public Health if RFK Jr. Is Allowed to 'Go Wild'
Could Avian Flu Cause Our Next Pandemic?
Global pandemic accord: Where the talks stand
An Update on Therapeutics for COVID-19
Trust in scientists improves, still below pre-COVID levels

Share This Article